Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Non-Current Liabilities (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Total Non-Current Liabilities readings, the most recent being $249500.0 for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 7.73% to $249500.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $249500.0, a 7.73% decrease, with the full-year FY2025 number at $249500.0, down 1.87% from a year prior.
  • Total Non-Current Liabilities reached $249500.0 in Q1 2026 per CBIH's latest filing, roughly flat from $249500.0 in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $326937.0 in Q4 2024, with the low at $249500.0 in Q2 2023.
  • A 4-year average of $263731.1 and a median of $249500.0 in 2023 define the central range for Total Non-Current Liabilities.
  • Year-over-year, Total Non-Current Liabilities increased 15.35% in 2024 and then fell 23.69% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $283420.0 in 2023, then increased by 15.35% to $326937.0 in 2024, then fell by 23.69% to $249500.0 in 2025, then changed by 0.0% to $249500.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Total Non-Current Liabilities are $249500.0 (Q1 2026), $249500.0 (Q4 2025), and $249500.0 (Q3 2025).